Published in Vaccine Weekly, February 18th, 2004
VaxGen was formed in 1995 to develop an HIV vaccine but has more recently shifted its focus to other biologic products, particularly biodefense vaccines.
Donald P. Francis, MD, DSc, president, and Phillip Berman, PhD, senior vice president of research and development are leaving the company and stepping down from the company's board of directors. Both will remain as consultants to the company.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly